Intrinsic Value of S&P & Nasdaq Contact Us

Sintx Technologies, Inc. SINT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
37/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Sintx Technologies, Inc. (SINT) has a negative trailing P/E of -0.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -229.18%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -229.18% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
37/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SINT

Valuation Multiples
P/E (TTM)-0.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.54
P/S Ratio7.32
EV/EBITDA-0.7
Per Share Data
EPS (TTM)$-6.16
Book Value / Share$1.06
Revenue / Share$0.37
FCF / Share$-3.16
Yields & Fair Value
Earnings Yield-229.18%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -140.7 2.05 162.47 153.37 0.27%
2017 -208.8 2.95 357.99 173.53 -
2018 -45.5 0.61 46.88 4,144.94 -
2019 -96.7 1.11 89.13 672.94 -
2020 -732.9 8.55 199.65 8,672.80 -
2021 -284.6 -42.01 154.09 4,372.29 -
2022 -48.5 -3.26 102.37 971.58 -
2023 -3.5 0.10 3.34 11.15 -
2024 -0.2 0.00 0.67 2.09 -
2025 -0.6 0.01 3.66 10.52 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-32,255.40 $15.23M $-16.6M -109%
2017 $-9,395.07 $11.23M $-9.33M -83.1%
2018 $-2,253.98 $95K $-8.65M -9107.4%
2019 $-311.65 $689K $-4.85M -703.8%
2020 $-41.92 $594K $-7.31M -1231.1%
2021 $-39.75 $606K $-9.82M -1621%
2022 $-51.96 $601K $-16.49M -2743.6%
2023 $-19.42 $2.63M $-8.26M -314.4%
2024 $-148,016.00 $2.89M $-11.02M -381.8%
2025 $-6.16 $1.02M $-17.08M -1678.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-2.13 $-2.21 – $-2.05 $2.12M $2.06M – $2.19M 1
2027 $0.00 $0.00 – $0.00 $6.67M $6.47M – $6.87M 0
2028 $0.00 $0.00 – $0.00 $14.89M $14.43M – $15.34M 0
2029 $0.89 $0.54 – $1.24 $58.3M $40.47M – $76.13M 1
2030 $1.54 $0.93 – $2.15 $81.5M $56.57M – $106.43M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message